HIGHLIGHTS
- who: He Li from the Zhujiang Hospital, China Purdue, United States have published the article: A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer, in the Journal: (JOURNAL)
- what: The authors focus on analyzing the possible biological behavior of metabolism-associated genes in the prognosis and development of PCa by bioinformatics analysis and functional cell assays. The authors developed a novel system according to metabolic genes to predict the efficacy of immunotherapy. This study investigated the expression patterns, prognostic value, and potential mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.